Start New EnglishEspañol中文РусскийالعربيةTiếng ViệtFrançaisDeutsch한국어Tagalog Library Performance
ALL MEDICAL CODES IN CATEGORY Temporary Codes Q0035-Q9992 > Anti-Inflammatory Medication and Chemotherapy Medication Q5103-Q5111

2025 HCPCS code Q5110

1 mcg of Nivestym™ (filgrastim-aafi), a granulocyte colony-stimulating factor (G-CSF), administered via subcutaneous injection or intravenous infusion to stimulate granulocyte production.

2025 HCPCS code Q5108

This HCPCS code represents 0.5 mg of pegfilgrastim-jmdb (Fulphila), a biosimilar used to reduce infection risk in patients undergoing myelosuppressive chemotherapy.

2025 HCPCS code Q5106

Injection, epoetin alfa-epbx, biosimilar, (Retacrit) (for non-ESRD use), 1000 units

2025 HCPCS code Q5104

Infliximab-abda (Renflexis), 10 mg

2025 HCPCS code Q5107

Injection, bevacizumab-awwb, biosimilar, 10 mg

2025 HCPCS code Q5103

Infliximab-dyyb injection, biosimilar to infliximab, 10 mg

2025 HCPCS code Q5105

Injection, epoetin alfa-epbx, biosimilar, (retacrit), 100 units